2020 Year Review

Chair’s Statement

I am delighted to present Kooth plc’s maiden full year results as a public company following our successful listing on AIM in September 2020. It is also my first as Chair since joining Kooth last May.

Our IPO has already begun to deliver a number of strategic benefits to the Company, supporting our investment in product development, our clinical operating model, and expanding our team to pursue new market opportunities. We begin life as a public company in a position of financial strength, with a robust balance sheet and a net cash position. As a listed company we now operate with a high level of transparency that we know our customers, partners, and service users’ value.